253 related articles for article (PubMed ID: 16007207)
1. Hepatitis C virus core variants isolated from liver tumor but not from adjacent non-tumor tissue interact with Smad3 and inhibit the TGF-beta pathway.
Pavio N; Battaglia S; Boucreux D; Arnulf B; Sobesky R; Hermine O; Brechot C
Oncogene; 2005 Sep; 24(40):6119-32. PubMed ID: 16007207
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C viral proteins interact with Smad3 and differentially regulate TGF-beta/Smad3-mediated transcriptional activation.
Cheng PL; Chang MH; Chao CH; Lee YH
Oncogene; 2004 Oct; 23(47):7821-38. PubMed ID: 15334054
[TBL] [Abstract][Full Text] [Related]
3. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription.
Taniguchi H; Kato N; Otsuka M; Goto T; Yoshida H; Shiratori Y; Omata M
J Med Virol; 2004 Jan; 72(1):52-9. PubMed ID: 14635011
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived C-terminal mutations of Smad4 with decreased DNA binding activity and enhanced intramolecular interaction.
Kuang C; Chen Y
Oncogene; 2004 Feb; 23(5):1021-9. PubMed ID: 14647410
[TBL] [Abstract][Full Text] [Related]
7. Viral hepatitis and liver cancer: the case of hepatitis C.
Levrero M
Oncogene; 2006 Jun; 25(27):3834-47. PubMed ID: 16799625
[TBL] [Abstract][Full Text] [Related]
8. Smad3 has a critical role in TGF-beta-mediated growth inhibition and apoptosis in colonic epithelial cells.
Mithani SK; Balch GC; Shiou SR; Whitehead RH; Datta PK; Beauchamp RD
J Surg Res; 2004 Apr; 117(2):296-305. PubMed ID: 15047135
[TBL] [Abstract][Full Text] [Related]
9. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis.
Choi SH; Jeong SH; Hwang SB
Gastroenterology; 2007 Jan; 132(1):343-57. PubMed ID: 17241884
[TBL] [Abstract][Full Text] [Related]
10. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
Imoto S; Sugiyama K; Sekine Y; Matsuda T
FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
Cui Q; Lim SK; Zhao B; Hoffmann FM
Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622
[TBL] [Abstract][Full Text] [Related]
12. Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.
Kato N; Yoshida H; Ono-Nita SK; Kato J; Goto T; Otsuka M; Lan K; Matsushima K; Shiratori Y; Omata M
Hepatology; 2000 Aug; 32(2):405-12. PubMed ID: 10915750
[TBL] [Abstract][Full Text] [Related]
13. [Construction and expression of plasmids containing different truncated core proteins of hepatitis C virus derived from tumor and non-tumor tissues].
Yan XB; Chen Z; Delphine B; Nicole P; Christian B
Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):643-7. PubMed ID: 15623368
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling.
Seo T; Park J; Choe J
Cancer Res; 2005 Mar; 65(5):1738-47. PubMed ID: 15753369
[TBL] [Abstract][Full Text] [Related]
15. Smad2 and Smad4 gene mutations in hepatocellular carcinoma.
Yakicier MC; Irmak MB; Romano A; Kew M; Ozturk M
Oncogene; 1999 Aug; 18(34):4879-83. PubMed ID: 10490821
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways.
Koike K
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S108-11. PubMed ID: 17567457
[TBL] [Abstract][Full Text] [Related]
17. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice.
Moriya K; Fujie H; Shintani Y; Yotsuyanagi H; Tsutsumi T; Ishibashi K; Matsuura Y; Kimura S; Miyamura T; Koike K
Nat Med; 1998 Sep; 4(9):1065-7. PubMed ID: 9734402
[TBL] [Abstract][Full Text] [Related]
18. Expression of Smad7 in hepatocellular carcinoma and dysplastic nodules: resistance mechanism to transforming growth factor-beta.
Park YN; Chae KJ; Oh BK; Choi J; Choi KS; Park C
Hepatogastroenterology; 2004; 51(56):396-400. PubMed ID: 15086168
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of TGF-beta-Smad3 signaling leads to enhanced neointimal hyperplasia with diminished matrix deposition in response to vascular injury.
Kobayashi K; Yokote K; Fujimoto M; Yamashita K; Sakamoto A; Kitahara M; Kawamura H; Maezawa Y; Asaumi S; Tokuhisa T; Mori S; Saito Y
Circ Res; 2005 Apr; 96(8):904-12. PubMed ID: 15790953
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma.
Rüster B; Zeuzem S; Roth WK
Biochem Biophys Res Commun; 1996 Feb; 219(3):911-5. PubMed ID: 8645278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
